Our preliminary data showed a trend towards increased YAP/TAZ protein expression in JAM-A overexpressing breast cancer cells (Figure S18); potentially suggesting a mechanism to account for increased β-catenin expression and transcriptional activity in the JAM-overexpressing tumorigenic cellular model. This evidence concerns the gene F11R and breast carcinoma.